← SynDRA
VE-821
SynDRA canonical compound SYN0049734 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | ATR |
|---|
| Mechanism of action | ATR kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- ATR kinase inhibitor
- ATR inhibitor
Cross-references
Synonyms
- 3-AMINO-6-(4-(METHYLSULFONYL)PHENYL)-N-PHENYLPYRAZINE-2-CARBOXAMIDE (VE-821)
- ATR INHIBITOR IV
- ATR serine/threonine protein kinase inhibitors (cancer), Oxford University
- ATR serine/threonine protein kinase inhibitors (cancer), Vertex Pharmaceuticals
- BF884TQ935
- VE821 cpd
- RefChem:193879
- MFCD19443686
- VE821
- ATR Inhibitor IV
- MLS006011215
- UNII-BF884TQ935
- GTPL8042
- orb1304605
- SCHEMBL2483543
- SCHEMBL30200156
- EX-A530
- CHEBI:124916
- GLXC-03729
- HMS3653B19
- HMS3673C07
- HMS3744G05
- BDBM50341733
- NSC761070
- AKOS025212610
- CCG-268268
- CS-0238
- EBC-224028
- NSC-761070
- SB19277
- VE-821?
- NCGC00346444-01
- NCGC00346444-05
- NCGC00346444-07
- AC-30933
- AS-72494
- BV168070
- DA-78848
- HY-14731
Look up VE-821 in the interactive SynDRA portal →